ADC Therapeutics SA
ADCT- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001771910
No open-market purchases or sales by ADC Therapeutics SA insiders were filed in the last 90 days; 113 institutions reported holding it in 13F filings for Q2 2026, worth $86.3M in total; no superinvestor holds it.
Superinvestors holding ADCT, Q2 2026
No superinvestor reported holding ADCT in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of ADCT each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q4 2022
0 superinvestors holding at quarter end
- Sold out
- HHLR Advisors (Hillhouse)